Last deal

$62M

Amount

Series B

Stage

04.03.2024

Date

3

all rounds

$111M

Total amount

date founded

Financing round

General

About Company
Nocion Therapeutics develops pharmaceuticals to treat neurogenic inflammation conditions.

Industry

Sector :

Subsector :

Also Known As

Nocion, Carica Health

founded date

01.01.2017

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company creates "nocions," a new type of therapy that targets activated sensory neurons and enters activated nociceptors via large-pore channels, blocking all sodium channels to provide targeted relief for serious conditions such as cough, itch, pain, and inflammation. Their small molecule charged sodium channel blockers are designed to provide durable and robust local analgesic effects while minimizing numbness or paralysis and other systemic off-target effects. Nocion Therapeutics' mission is to safely alleviate suffering for millions of patients with conditions arising from activated sensory neurons.
Contacts

Contact Email

Phone number

Social url

Legal Names

Legal name

Nocion Therapeutics, Inc.
Similar Companies
1000
PNP Therapeutics

PNP Therapeutics

PNP Therapeutics is a biopharmaceutical company developing technology and proprietary products for cancer treatment.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Birmingham, AL, USA

total rounds

7

total raised

$2.59M
Realm Therapeutics

Realm Therapeutics

Realm Tx is a biopharmaceutical company that develops immunomodulatory therapies to treat inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Malvern, PA 19355, USA

total rounds

1

total raised

$26M
Relmada Therapeutics

Relmada Therapeutics

Relmada Therapeutics is a clinical-stage biotechnology company developing new drug products to address central nervous system diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

New York, NY, USA

total rounds

10

total raised

$306.13M
viDA Therapeutics

viDA Therapeutics

viDA Therapeutics develops treatments for chronic inflammatory and age-related diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Vancouver, BC, Canada

total rounds

3

total raised

$2.55M

Financials

Funding Rounds
4
3

Number of Funding Rounds

$111M

Money Raised

Their latest funding was raised on 04.03.2024. Their latest investor Arkin Holdings. Their latest round Series B

Date 
Funding Round 
Investors 
Money Raised 
Lead 
Arkin Holdings

Arkin Holdings

Arkin Holdings empowers breakthrough healthcare companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Location

Herzliya, Israel

count Of Investments

22

count Of Exists

1
Monograph Capital

Monograph Capital

Monograph Capital is a life sciences venture firm that funds and supports innovative companies in the field of life sciences.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Biotechnology, Life Science, Venture Capital

Location

London, UK

count Of Investments

10
Co-Investors
Investors
8
2

Number of lead investors

8

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series A, Series B
Yes
Series B
Arkin Holdings

Arkin Holdings

Arkin Holdings empowers breakthrough healthcare companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Location

Herzliya, Israel

count Of Investments

22

count Of Exists

1
Pini Orbach

Pini Orbach

Pini Orbach is a head of Pharma at Arkin Holdings & Arkin Bio Ventures.

Mission BioCapital

Mission BioCapital

Mission BioCapital is a life science venture capital firm that invests in early-stage companies in the biotech sector.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Biotechnology

Location

Cambridge, MA, USA

total rounds

1

total raised

$11M

count Of Investments

55

count Of Exists

11
Monograph Capital

Monograph Capital

Monograph Capital is a life sciences venture firm that funds and supports innovative companies in the field of life sciences.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Biotechnology, Life Science, Venture Capital

Location

London, UK

count Of Investments

10

People

Founders
3
Bruce Levy
Bruce Levy

Bruce Levy

Dr. Bruce Levy is a Co-Founder of Nocion Therapeutics.

current job

Nocion Therapeutics
Nocion Therapeutics

organization founded

1

Bruce Levy

Bruce Bean
Bruce Bean

Bruce Bean

current job

Nocion Therapeutics
Nocion Therapeutics

organization founded

1

Bruce Bean

Clifford J Woolf
Clifford J Woolf

Clifford J Woolf

Dr. Clifford J. Woolf works on pain and on the regeneration and degeneration of the nervous system, with a particular focus on neurological disease modeling and drug screening in patient iPS cell derived neurons. He was born in South Africa, where he earned his MD and PhD degrees. He moved to London in 1979 and became Professor of Neurobiology at University College London. In 1997 he was recruited by the Massachusetts General Hospital and Harvard Medical School (HMS) to serve as the first Richard J. Kitz Professor of Anesthesiology Research at HMS. In 2007 he was appointed Principal Faculty Member of the Harvard Stem Cell Institute and in 2010 was named director of the F. M. Kirby Neurobiology Center at Boston Children’s Hospital, and became Professor of Neurology and Neurobiology at HMS. Dr Woolf is deputy director of the Intellectual Developmental Disability Disorders Center at Boston Children’s Hospital and co-director of the neuroscience program of the Harvard Stem Cell Institute. Over his career Dr. Woolf has received many honors and prizes. He was awarded the Gill Distinguished Scientist award and the Reeve-Irvine medal this year and in 2015 the Kerr award from the American Pain Society, a Founders Award from the American Academy of Pain Medicine and became an honorary fellow of the Irish College of Anesthetists. He was awarded the Magnes medal in Israel in 2013 and selected to deliver the FE Bennett Memorial Lecture by the American Neurological Association in 2012. He was awarded a Javits Award from the NINDS at the NIH in 2011, delivered the Schmidt lecture at MIT in 2011, the Bonica Lecture for the International Society of the Study of Pain in 2010, was Visiting Professor at Columbia University in 2009 and received the Wall Medal from the Royal College of Anesthetists in the U.K also in 2009. In 2015 Dr Woolf was appointed to the Board of Scientific Councilors of the National Institute of Neurological Diseases and Stroke.

current job

QurAlis
QurAlis

organization founded

2

Clifford J Woolf

Employee Profiles
9
Christopher Silber

Christopher Silber

Chief Medical Officer

Kyle Lavigne

Senior manager of pharmaceutical development

Stephanie Gillis

Director of operations

Richard Batycky

Richard Batycky

President & CEO

Rick Batycky

CEO

Jim Ellis

Jim Ellis

CSO

Bruce Bean

Bruce Bean

Co-founder

Clifford J Woolf

Clifford J Woolf

Co-founder

Activity

Recent News
2
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week